MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KR-03-0211068
Supraceuticals Private Limited
Supraceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.37 Cr
Latest filing
Net loss · FY 2024
₹79.79 Lakh
Net margin -33.6%
EBITDA · FY 2024
-₹79.98 Lakh
EBITDA margin -33.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6.25 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Employees · EPFO
20
Provident fund records
Directors on board
5
As per MCA filings
About Supraceuticals Private Limited
Data last updated:
Supraceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2022PTC166848.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.25 Lakh. It is led by directors including Singatagere Chandrappa Venkatesha Murthy and Melige Ahmed Ashraf.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.37 Cr. For the same year it recorded a net loss of ₹79.79 Lakh (net margin -33.6%) and EBITDA of -₹79.98 Lakh (EBITDA margin -33.7%).
The company has about 20 employees on its provident fund (EPFO) records.
Supraceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0211068). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290KA2022PTC166848
Registration Number 166848
Incorporation Date 10 October 2022
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0211068
Key People
Singatagere Chandrappa Venkatesha Murthy Director Melige Ahmed Ashraf Director Prashanthkulkarni Director Recognitions & Rankings of Supraceuticals
Contact details
Supraceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.20 Shop No.3 Ground Floor 1st A Main 2nd Cross Aditya Nagar J.P Nagar 8th P, Hase, Bangalore, Karnataka, India – 560062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Supraceuticals Private Limited, buy the company report.
Comprehensive company report
Supraceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Supraceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Supraceuticals Private Limited, buy the company report.
Financials of Supraceuticals Private Limited
FY 2025 filings availableSupraceuticals Private Limited reported revenue of ₹2.37 Cr for FY 2024.
Revenue · FY 2024
₹2.37 Cr
Net loss · FY 2024
₹79.79 Lakh margin -33.6%
EBITDA · FY 2024
-₹79.98 Lakh margin -33.7%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹79.98 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹79.79 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -33.7% | |
| Net Profit Margin | -33.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Supraceuticals Private Limited, buy the company report.
Board of directors of Supraceuticals Private Limited
Supraceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Singatagere Chandrappa Venkatesha Murthy | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Melige Ahmed Ashraf | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Prashanthkulkarni | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Jayakrishnasetty Rajesh | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Ibrahim Mohammed | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
Auditor
Supraceuticals Private Limited is audited by ARSV AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARSV AND ASSOCIATES | FY 2023 | 237287 |
Shareholding
The shareholding of Supraceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Supraceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Supraceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supraceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Supraceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Supraceuticals Private Limited has 6 board changes on record since 2022: 5 appointments and 1 cessation. The latest: Ibrahim Mohammed ceased to be Additional Director on 30 Mar 2023.
AGM
Supraceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Supraceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Ibrahim Mohammed ceased to be Additional Director.
Appointed
Ibrahim Mohammed was appointed as Director.
Appointed
Jayakrishnasetty Rajesh was appointed as Director.
Appointed
Melige Ahmed Ashraf was appointed as Director.
Appointed
Prashanthkulkarni was appointed as Director.
Appointed
Singatagere Chandrappa Venkatesha Murthy was appointed as Director.
Incorporation
10 Oct 2022
Supraceuticals Private Limited was registered on 10 Oct 2022 with Roc Bangalore & aged 4 years 12 days as per MCA records.
Frequently asked questions
Supraceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 2022 (4+ years old) and is registered under CIN U24290KA2022PTC166848.
Supraceuticals has 5 current directors:
- Singatagere Chandrappa Venkatesha Murthy - Director
- Melige Ahmed Ashraf - Director
- Prashanthkulkarni - Director
- Jayakrishnasetty Rajesh - Director
- Ibrahim Mohammed - Director
The latest financial statements of Supraceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Supraceuticals is U24290KA2022PTC166848. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supraceuticals was incorporated on 10 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
Ibrahim Mohammed ceased to be Additional Director on 30 Mar 2023. Ibrahim Mohammed was appointed as Director on 06 Jan 2023. Jayakrishnasetty Rajesh was appointed as Director on 10 Oct 2022. Supraceuticals has 6 board changes on record in total.
Yes, Supraceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0211068).
The registered office of Supraceuticals is at No.20 Shop No.3 Ground Floor 1st A Main 2nd Cross Aditya Nagar J.P Nagar 8th P, Hase, Bangalore, Karnataka, India – 560062.
Supraceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Supraceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.